The result that the release of TNF-α and IL-6 was significantly decreased after S7 treatment suggested that the peptide might suppress the development of a cytokine storm via a rapid bactericidal effect in vivo, demonstrating that S7 is a promising therapeutic agent against bacterial infections in the clinical settings. The gene discussed is IL6; the disease is bacterial infectious disease.